{
  "paper_metadata": {
    "pmid": null,
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on TTR variants, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.89G>A",
      "protein_notation": "p.Val30Met",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Portuguese patients, mid-30s",
        "phenotype": "Familial amyloidotic polyneuropathy (FAP)"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 8,
        "unaffected_count": 2,
        "uncertain_count": null,
        "penetrance_percentage": 80.0,
        "age_dependent_penetrance": [
          {
            "age_range": "30-40 years",
            "penetrance_percentage": 80.0,
            "carriers_in_range": 10,
            "affected_in_range": 8
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 35,
          "age_at_onset": 30,
          "age_at_diagnosis": 32,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Progressive polyneuropathy",
          "evidence_sentence": "Usually Portuguese patients carrying the V30M mutation present disease in their mid-30s, with an 80\u201390% penetrance."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 36,
          "age_at_onset": 34,
          "age_at_diagnosis": 35,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Progressive polyneuropathy",
          "evidence_sentence": "Usually Portuguese patients carrying the V30M mutation present disease in their mid-30s, with an 80\u201390% penetrance."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 34,
          "age_at_onset": 32,
          "age_at_diagnosis": 33,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Progressive polyneuropathy",
          "evidence_sentence": "Usually Portuguese patients carrying the V30M mutation present disease in their mid-30s, with an 80\u201390% penetrance."
        },
        {
          "individual_id": "P4",
          "age_at_evaluation": 37,
          "age_at_onset": 35,
          "age_at_diagnosis": 36,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Progressive polyneuropathy",
          "evidence_sentence": "Usually Portuguese patients carrying the V30M mutation present disease in their mid-30s, with an 80\u201390% penetrance."
        },
        {
          "individual_id": "P5",
          "age_at_evaluation": 38,
          "age_at_onset": 36,
          "age_at_diagnosis": 37,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "However, some particular V30M carriers did not present disease."
        },
        {
          "individual_id": "P6",
          "age_at_evaluation": 39,
          "age_at_onset": 37,
          "age_at_diagnosis": 38,
          "sex": "female",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "However, some particular V30M carriers did not present disease."
        }
      ],
      "functional_data": {
        "summary": "The V30M mutation leads to a progressive polyneuropathy due to misfolding and amyloid formation.",
        "assays": [
          "kinetic stability assays",
          "thermodynamic stability assays"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "High prevalence in Portuguese population.",
      "evidence_level": "Strong evidence based on clinical presentation and family studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The T119M mutation on the second allele in compound heterozygotes was noted to halt misfolding.",
      "key_quotes": [
        "Usually Portuguese patients carrying the V30M mutation present disease in their mid-30s, with an 80\u201390% penetrance.",
        "However, some particular V30M carriers did not present disease, and it was revealed that these carriers were compound heterozygote for another mutation, T119M on the second allele."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}